Log in

NASDAQ:DXTR - Dextera Surgical Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume1.49 million shs
Average Volume423,525 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:DXTR
CUSIPN/A
Phone+1-650-3649975

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive DXTR News and Ratings via Email

Sign-up to receive the latest news and ratings for DXTR and its competitors with MarketBeat's FREE daily newsletter.


Dextera Surgical (NASDAQ:DXTR) Frequently Asked Questions

What is Dextera Surgical's stock symbol?

Dextera Surgical trades on the NASDAQ under the ticker symbol "DXTR."

How were Dextera Surgical's earnings last quarter?

Dextera Surgical Inc (NASDAQ:DXTR) posted its earnings results on Thursday, November, 9th. The medical instruments supplier reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.07) by $0.02. The medical instruments supplier earned $0.69 million during the quarter, compared to the consensus estimate of $0.62 million. View Dextera Surgical's Earnings History.

Has Dextera Surgical been receiving favorable news coverage?

Headlines about DXTR stock have trended very negative on Sunday, according to InfoTrie. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Dextera Surgical earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned news headlines about the medical instruments supplier a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Dextera Surgical.

What other stocks do shareholders of Dextera Surgical own?

Who are Dextera Surgical's key executives?

Dextera Surgical's management team includes the folowing people:
  • Robert Y. Newell IV, Principal Executive Officer, Chief Financial Officer, Vice President - Finance (Age 67)
  • Michael A. Bates, Director (Age 57)
  • Julian Nikolchev, Director (Age 62)

What is Dextera Surgical's official website?

The official website for Dextera Surgical is http://www.dexterasurgical.com/.

How can I contact Dextera Surgical?

Dextera Surgical's mailing address is 900 Saginaw Dr, REDWOOD CITY, CA 94063-4753, United States. The medical instruments supplier can be reached via phone at +1-650-3649975 or via email at [email protected]


MarketBeat Community Rating for Dextera Surgical (NASDAQ DXTR)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  380 (Vote Outperform)
Underperform Votes:  244 (Vote Underperform)
Total Votes:  624
MarketBeat's community ratings are surveys of what our community members think about Dextera Surgical and other stocks. Vote "Outperform" if you believe DXTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DXTR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: VIX - Volatility Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel